Pluristem Stem Cell therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA to Treat Acute Radiation Syndrome
Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the…
